Advancement on the Association between Gut Microbiota and Autism Spectrum Disorder in Children
Annals of Nutrition and Metabolism · 31.12.2025 · 82 (2) · 115-129
DOI: 10.1159/000549716 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of Nutrition and Metabolism, online erschienen am 31.12.2025. Verfasst von Adila Abulaiti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kashi University School of Medicine, Institute of etiology and prevention of metabolic diseases in Pamir Plateau Area, Xinjiang, China. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background: Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by deficits in social interaction, communication, and the presence of restricted, repetitive behaviors. The rising global prevalence of ASD suggests a multifactorial etiology involving genetic, environmental, and neurodevelopmental factors. This review explores the establishment of the early life microbiome, highlighting rapid microbial colonization from maternal and environmental sources. Emerging evidence indicates that delivery mode and infant feeding practices may influence ASD susceptibility. Although the concept of a sterile intrauterine environment remains debated, its investigation is valuable. Summary: This review provides a comprehensive analysis of the interplay between diet, gastrointestinal symptoms, and ASD, evaluates the gut-brain axis as a mechanistic framework, and assesses the therapeutic potential of microbial interventions. The bidirectional “microbiota-gut-brain axis” has emerged as a critical pathway linking gut microbiota and brain function, offering potential therapeutic targets for ASD. Dietary patterns in children with ASD are often characterized by selectivity and restriction, which may disrupt gut microbiota composition and exacerbate gastrointestinal symptoms, thereby increasing ASD risk. Nutritional interventions and early behavioral therapies are thus essential. Key Messages: The gluten-free, casein-free diet remains controversial, with inconsistent evidence regarding its efficacy. Probiotic supplementation shows strain-specific effects, necessitating rigorous evaluation before clinical application. Given the heterogeneity of ASD, pharmacological treatments have shown limited universal efficacy. While promising findings have emerged from research on probiotics, prebiotics, and fecal microbiota transplantation, further well-designed clinical studies are needed to elucidate the complex etiology of ASD and validate therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kashi University School of Medicine, Institute of etiology and prevention of metabolic diseases in Pamir Plateau Area, Xinjiang, China.
- Kashi University School of Medicine, Institute of etiology and prevention of metabolic diseases in Pamir Plateau Area, Xinjiang, China, chg@gdmu.edu.cn.
- The First Dongguan Affiliated Hospital, Guangdong Medical University, Guangdong, China, chg@gdmu.edu.cn.
Zitieren
APA
Abulaiti, A., Yu, H., Ma, J., Wuji, A., & Chi, H. (2025). Advancement on the Association between Gut Microbiota and Autism Spectrum Disorder in Children. Annals of Nutrition and Metabolism, 82(2), 115-129. https://doi.org/10.1159/000549716
Vancouver
Abulaiti A, Yu H, Ma J, Wuji A, Chi H. Advancement on the Association between Gut Microbiota and Autism Spectrum Disorder in Children. Annals of Nutrition and Metabolism. 2025;82(2):115-129. doi:10.1159/000549716
BibTeX
@article{Abulaiti2025,
author = {Abulaiti, Adila and Yu, Huanhuan and Ma, Junmei and Wuji, Anikezi and Chi, Honggang},
title = {Advancement on the Association between Gut Microbiota and Autism Spectrum Disorder in Children},
journal = {Annals of Nutrition and Metabolism},
year = {2025},
volume = {82},
number = {2},
pages = {115--129},
doi = {10.1159/000549716}
}
EUVIMED